NCT04985994 (Micro-STOP) is a clinical trial in Tuberculosis, sponsored by Khyber Medical University Peshawar.

Who is sponsoring NCT04985994?

NCT04985994 is sponsored by Khyber Medical University Peshawar.

What condition does NCT04985994 study?

NCT04985994 studies Tuberculosis.

Is NCT04985994 still recruiting?

NCT04985994 is currently completed. Last updated 10 October 2024.

Last reviewed 2024-10-10 · How we verify

NCT04985994: Micro-STOP

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Potential Role of Microbiome in Tuberculosis

Completed Last updated 10 October 2024

What this trial tests

trial in Tuberculosis in 450 participants. Completed in 31 August 2024.

Timeline

22 August 2021

Primary endpoint
31 March 2024

31 August 2024

Quick facts

Lead sponsor	Khyber Medical University Peshawar
Status	Completed
Study type	OBSERVATIONAL
Enrollment	450
Start date	22 August 2021
Primary completion	31 March 2024
Estimated completion	31 August 2024
Sites	2 locations across Pakistan

Conditions studied

Tuberculosis — all drugs for Tuberculosis →

Sponsor

Khyber Medical University Peshawar

Who can join

Adults 18 to 65, any sex, with Tuberculosis. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Tuberculosis (TB), caused by Mycobacterium tuberculosis (Mtb), is a deadly infectious disease and major global public health problem. Recent evidence from animal studies suggests that the microbiome plays a role in TB pathogenesis and immune response. However, until now, no similar study has been performed in humans and thus any influence of the microbiota on TB or vice versa remains unknown.

Publications & conference data

2 peer-reviewed publications reference this trial (live from Europe PMC):

Exploring the role of Microbiome in Susceptibility, Treatment Response and Outcome among Tuberculosis Patients from Pakistan: study protocol for a prospective cohort study (Micro-STOP).
Shahzad M, Andrews SC, Ul-Haq Z. · · 2022 · cited 2× · PMID 35672071 · DOI 10.1136/bmjopen-2021-058463
Exploring the Role of Microbiome in Susceptibility, Treatment Response and Outcome among Tuberculosis Patients from Pakistan; Study Protocol for a Prospective Cohort Study (Micro-STOP)
Shahzad M, Haq ZU, Andrews SC. · · 2021 · DOI 10.1101/2021.11.10.21266176

Verify or expand the search:

Other recruiting trials for Tuberculosis

Currently open trials in the same condition.

NCT05917210 — Peer-led Implementation of TB-HIV Education and Adherence Counseling in Uganda · NA · recruiting
NCT07170735 — Quantitative Measurement of Plasma and Urine MTB Cell-free DNA Level · recruiting
NCT07484490 — Effects of the Active Cycle of Breathing Technique With and Without Balloon Blowing Therapy in Tuberculosis · NA · recruiting
NCT06318416 — Precision Rifampin Trial for Personalized Dosing · Phase 1 · recruiting
NCT07170800 — A Phase 2b Clinical Study of JDB0131 Benzenesulfonate Tablets · Phase 2 · recruiting

Other Khyber Medical University Peshawar trials

Trials by the same sponsor.

NCT07425275 — Integrated Oral Care Intervention for Xerostomia in Diabetes Patients · NA · recruiting
NCT07425249 — Impact of Chewing Gum on Postoperative Gut Motility in Gastrointestinal Surgery Patients · NA · recruiting
NCT07346326 — Comparative Study of Functional Outcomes Between Peroneus Longus and Hamstring Tendon Autografts in Arthroscopic ACL Rec · NA · recruiting
NCT07354776 — Effect of Isometric Neck Exercises on Cervicogenic Headache, Cortisol, and BDNF in Adolescents With Smartphone Addiction · NA · recruiting
NCT07336914 — Effect of Conventional vs Intensive Management on Gestational Diabetes and Maternal Fetal Outcomes · NA · recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT04985994 (US National Library of Medicine, public domain)
Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Khyber Medical University Peshawar
Last refreshed: 10 October 2024

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04985994.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing